The efficacy of gabapentin on tinnitus

Phase 3

• Conditions: H93.1; Idiopathic tinnitus.; Tinnitus

• Registration Number: IRCT20200127046283N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

All the patient with idiopathic tinnitus referred to the ENT clinic of the Al-Zahra hospital
Age between 18 and 65
Satisfaction to enter this study
Patient assistance to use the drug
No pregnancy , lactescent, or plan to pregnancy in the next 6 months
Normal audiometry test

Exclusion Criteria

Use narcotic or alcohol or sedative drugs in the past 48 hours
Use MAOI, SSRI, TCA ,phenothiazine, soporific drugs in the past
Sensitivity to gabapentine
No satisfaction with being a case study in this study
No assistance to use the drug
Patient with pulsative tinnitus
Patient with acute / choronic internal or middle ear infection
Patient with thyroid disease
Patient with rheumatologic disease
Deals with noisy workplace
Age more than 65 years
Simultaneous use of other drugs except for gabapentin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The score of tinnitus in tinnitus severity index questionnaire and visual analogue scale. Timepoint: The amount of tinnitus at the beginning of the study and 1, 2 and 3 months after starting the drug and placebo will be measured. Method of measurement: Tinnitus severity index questionnaire, visual analogue scale and 5 point scale for satisfaction.

Secondary Outcome Measures

Name	Time	Method
Side effects of prescribed drug. Timepoint: 1-2-3 months after using drug. Method of measurement: ask about vertigo? nasea? drowsiness? biurred vision ?fatigue.